ADVERTISEMENT

Amanta Healthcare IPO Subscribed 19.62 Times On Day 2

The GMP of Amanta Healthcare IPO fell to Rs 12 as of 7:37 p.m., as per InvestorGain.

Amanta Healthcare IPO
Amanta Healthcare IPO was fully subscribed hours within launch on Monday (Photo:  LinkedIn/@Amanta Healthcare Ltd.)
Show Quick Read
Summary is AI Generated. Newsroom Reviewed

Amanta Healthcare Ltd.'s initial public offering entered its second day of subscription on Tuesday. The pharmaceutical company, specialising in sterile products like large and small volume parenterals, has floated a Rs 126-crore IPO.

The entire IPO is a fresh issue of shares, with no offer-for-sale component. The price band is set at Rs 120 to Rs 126 apiece, with the IPO closing on Wednesday, Sept. 3.

Amanta Healthcare is set to utilise the IPO proceeds to boost its capex plans. The minimum amount of investment required by a retail investor is Rs 14,994. Investors can bid for a minimum of 119 shares and in multiples thereof.

The tentative date of allotment of shares to IPO investors is Sept. 4. Amanta Healthcare will likely list on the BSE and NSE on Sept. 9.

Opinion
Amanta Healthcare IPO GMP Trends As Mainboard Issue Fully Subscribed On Day 1

Amanta Healthcare Subscription Details

Amanta Healthcare IPO was subscribed 19.62 times as of 5 p.m. on Tuesday.

  • Qualified Institutions: 0.53 times

  • Non-Institutional Buyers: 36.40 times

  • Retail Investors: 23.31 times

Amanta Healthcare IPO: Key Details

  • Open date: Sept. 1

  • Close date: Sept. 3

  • Allotment date: Sept. 4

  • Price Band: Rs 120-126

  • Tentative Listing date: Sept. 9

  • IPO size: Rs 126 crore

  • Fresh issue: 1 crore shares aggregating to Rs 126 crore.

  • Minimum bid: Lot size of 119 shares

Amanta Healthcare GMP

The grey market premium of Amanta Healthcare IPO fell to Rs 12 as of 7:37 p.m., as per InvestorGain. The GMP price indicated a 9.52% listing gain as indicated by the implied listing price of Rs 138.

Note: GMP or grey market price is not an official price quote for the stock and is based on speculation.

Opinion
Upcoming IPO: Leap India Files Draft Papers With SEBI To Raise Rs 2,400 Crore Via Fresh Issue, OFS
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit